For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.
Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...
No heartbeat. No breathing. No pulse. But Amanda Boley’s insurance company said she still should have obtained preapproval.
Shares of major healthcare companies Humana (NYSE: NYSE:HUM), CVS Health (NYSE: NYSE:CVS), Elevance Health, and Cigna (NYSE:CI) fell sharply in Friday's trading session, following a broader industry ...
No heartbeat. No breathing. No pulse. But Amanda Boley’s insurance company said she still should have obtained preapproval.
Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...
Humana Inc. shares (HUM) slid 4.5%, CVS Health Corp.'s stock (CVS) gave up 1.7%, Centene Corp. shares (CNC) slid 1.5% and Elevance Health Inc.'s stock (ELV) was down 1.9%.
The policies are usually popular in states where they're available, and the company has a large network of doctors and hospitals. Keep in mind that Anthem's customer service reputation varies widely ...
Physicians tell the AMA that delayed and disrupted care continues to be a predictable and maddening part of the patient experience, as widespread use of prior authorization programs by the health ...
But the treatments had destroyed his liver. Doctors recommended a transplant. His insurer, Elevance Health, rejected the claim and three appeals in letters referencing research showing a new liver ...
Physicians tell the AMA that delayed and disrupted care continues to be a predictable and maddening part of the patient experience, as widespread use of prior authorization programs by the health ...